Advertisement
Research Article

CD40-Activated B Cell Cancer Vaccine Improves Second Clinical Remission and Survival in Privately Owned Dogs with Non-Hodgkin's Lymphoma

  • Karin U. Sorenmo equal contributor mail,

    equal contributor Contributed equally to this work with: Karin U. Sorenmo, Robert H. Vonderheide, Nicola J. Mason

    nmason@vet.upenn.edu (NJM); rhv@exchange.upenn.edu (RHV); karins@vet.upenn.edu (KUS)

    Affiliation: Department of Clinical Studies, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

    X
  • Erika Krick,

    Affiliation: Department of Clinical Studies, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

    X
  • Christina M. Coughlin,

    Affiliation: Department of Medicine, School of Medicine, Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

    X
  • Beth Overley,

    Affiliation: Department of Clinical Studies, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

    X
  • Thomas P. Gregor,

    Affiliation: Department of Clinical Studies, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

    X
  • Robert H. Vonderheide equal contributor mail,

    equal contributor Contributed equally to this work with: Karin U. Sorenmo, Robert H. Vonderheide, Nicola J. Mason

    nmason@vet.upenn.edu (NJM); rhv@exchange.upenn.edu (RHV); karins@vet.upenn.edu (KUS)

    Affiliations: Department of Medicine, School of Medicine, Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

    X
  • Nicola J. Mason equal contributor mail

    equal contributor Contributed equally to this work with: Karin U. Sorenmo, Robert H. Vonderheide, Nicola J. Mason

    nmason@vet.upenn.edu (NJM); rhv@exchange.upenn.edu (RHV); karins@vet.upenn.edu (KUS)

    Affiliations: Department of Clinical Studies, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

    X
  • Published: August 31, 2011
  • DOI: 10.1371/journal.pone.0024167

About the Authors

Karin U. Sorenmo, Erika Krick, Beth Overley, Thomas P. Gregor, Nicola J. Mason
Department of Clinical Studies, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
Nicola J. Mason
Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
Christina M. Coughlin, Robert H. Vonderheide
Department of Medicine, School of Medicine, Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
Robert H. Vonderheide, Nicola J. Mason
Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

Corresponding Authors

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: KUS CMC RHV NJM. Performed the experiments: KUS EK CMC BO RHV NJM. Analyzed the data: KUS TPG RHV NJM. Contributed reagents/materials/analysis tools: KUS RHV NJM. Wrote the paper: KUS RHV NJM.